Integrated Biotherapeutics, LLC
Rockville, MD Doing business as IBT Bio Services IBT Bioservices
- UEI
- XNTHMSN2JJP5
- CAGE
- 463Q7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 4 Research Ct #300, Rockville, MD 20850, USA
- Website
- ibtbioservices.com
- Founded
- 2009
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| The purpose of this purchase order is to provide the national institute of environmental health sciences (niehs) /… | Office of Logisitics and Acquisition Operations | $75,000 | |
| Medical r & d | Veterans Integrated Service Network 4 | $46,090 | |
| Integrated biotherapeutics, INC.:1150828 [25-003252] laboratory and testing services. | National Cancer Institute | $17,964 | |
| This service is needed to test the efficacy a lambda phage vaccine engineered with segments of the covid-19 spike… | National Cancer Institute | $16,869 | |
| Mouse experiments for our phage-vector construct of a neuroblastoma vaccine is needed to test the efficacy of the… | National Cancer Institute | $16,869 |
About Integrated Biotherapeutics, LLC
Integrated Biotherapeutics, LLC (doing business as IBT Bio Services), a self-certified small disadvantaged business based in Rockville, Maryland, delivers biomedical research and laboratory testing services to federal agencies as a prime contractor (94% of recent awards), with specialized focus on vaccine research, immunotherapy candidate evaluation, and infectious disease response. The vendor operates as a partnership or limited liability company structured as a small business, with primary NAICS concentration in biotechnology research and development and manufacturing of biological products.
The vendor's customer base is heavily concentrated in the Department of Health and Human Services. The top five customer agencies account for 82% of awards by count, led by the National Institute of Allergy and Infectious Diseases (13 awards, $43 thousand combined potential value) and the National Cancer Institute (3 awards, $52 thousand). However, dollar concentration diverges sharply: a single NIAID award carries $59.1 million combined potential value, representing 86% of the vendor's total portfolio ($68.4 million across 34 awards). The Defense Threat Reduction Agency anchors $8.4 million, and the Department of the Army Medical Command rounds out the major-dollar customers at $840 thousand. The vendor also holds recent task orders with the Veterans Integrated Service Network and the Office of the Assistant Secretary for Preparedness and Response. One parent vehicle appears in the source — an indefinite delivery contract (75A50123D00003) with one task order — though the vendor's award structure is predominantly direct federal agency purchases.
Representative prime work includes a $59.1 million NIAID award for vaccine and immunotherapy development; a $46.1 thousand June 2026 purchase order with Veterans Integrated Service Network 10 for medical research and development services in Ann Arbor, Michigan (ultimate completion June 2027); a $17.9 thousand February 2025 purchase order with the National Cancer Institute for laboratory and testing services; and prior National Cancer Institute awards for lambda phage vaccine efficacy testing in animal models and neuroblastoma vaccine candidate mouse experiments. The vendor subcontracts to Advanced Technology International on a correlate-of-protection study supporting Sudan virus vaccine candidate development (October 2024 award).
Activity volume is sparse and episodic — one award in each of 2024, 2025, and 2026, with two awards in 2022 and two in 2020 — reflecting the project-driven nature of federal biomedical research procurement. SCI-reported invoiced revenue was $1.5 million in FY2022 (covering 2.9 FTEs) with minimal subsequent SCI-captured activity (0.1 FTEs in FY2024). Government-paid rates on SCI-reportable prime contracts ran at $181.92 per hour across the source period. Across SCI-reportable prime contracts, subcontractors performed 27% of total hours, with four named subs engaged. One award (the Veterans Integrated Service Network purchase order for $46 thousand) faces ultimate completion within the next twenty-four months and represents the vendor's only near-term recompete exposure.
Quick answers
What is Integrated Biotherapeutics, LLC's UEI?
Integrated Biotherapeutics, LLC's Unique Entity ID (UEI) in SAM.gov is XNTHMSN2JJP5.
What is Integrated Biotherapeutics, LLC's CAGE code?
Integrated Biotherapeutics, LLC's CAGE code is 463Q7.
What is Integrated Biotherapeutics, LLC's primary NAICS code?
Integrated Biotherapeutics, LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Integrated Biotherapeutics, LLC located?
Integrated Biotherapeutics, LLC's physical address in SAM.gov is 4 Research Ct #300, Rockville, MD 20850, USA.
Is Integrated Biotherapeutics, LLC registered in SAM.gov?
Yes. Integrated Biotherapeutics, LLC's SAM.gov registration is active through October 28, 2026.
What is Integrated Biotherapeutics, LLC's most recent federal award?
Integrated Biotherapeutics, LLC's most recent federal contract award is The purpose of this purchase order is to provide the national institute of environmental health sciences (niehs) /… (75N98026P01439), from Office of Logisitics and Acquisition Operations, on September 1, 2026.
On GovTribe
See Integrated Biotherapeutics, LLC's full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors